How has #aiforhealth evolved in the last 20years & how are the big strategics adopting it? Very unique insight from @CoreyZankowski and @TerryDuesterhoeft. The @CELS_SFO#canadalifesciences#showcase was a unique opportunity 2 gather execs, strategics, VCs & innovative startups
More investment is going into healthcare bc of the pandemic. There is a convergence happening w tech and healthcare by leveraging data. @SUBiodesign#ParthaRay#CanadaInTheValley Showcase
Key Themes to Future Commercialization #CanadaInTheValley
“Companies that have a balance between spend on clinical strategy - the number of studies needed - and good evidence coming out for FDA and market adoption.” #healthquestCapital#Nuespera@genentech
Finding a lead is critical. Without the lead, you are nowhere. Be aware of investors that say they are "in" once you find a lead. The lead is critical. They use their contacts and reputation to round out your syndicate. #GlennReicin@AlladaptImmuno#CanadaInTheValley
Excited to share that @Obioscience Organization is hosting its 6th investment summit from Feb 8th to 10th, 2023. Follow the link below for more info and to register.
https://t.co/KiCpzho4YJ
We are back with our final workshop for the Valley Ready Spring 2022 Cohort on 'Scaling Teams & Building Company Culture'.
@kmcdougall is the President and founder of @Artemis_Canada, an executive search firm with offices in Waterloo and Toronto.
We have @angelemaki joining us this Friday to share her valuable expertise on Corporate Strategics as a part of our #valleyready workshop. Dr. Maki is a business development executive with nearly twenty years of deal-making experience spanning small biotech and big pharma.
Hope you all had a great Canada Day and 4th of July celebration!
We are excited to have 2 amazing speakers Cheryl Reicin & @AdamFalconi from our sponsor company @TorysLLP for this Friday's Workshop on 'Licensing and Joint Ventures' as a part of our VR Program-Spring 2022.
The U.S. healthcare is expensive, complex, & the incentives across stakeholders are not typically aligned.
We’re joined by industry veterans, Ali from @CalaHealth and Scott from @genentech, to talk through how startups navigate through the interconnected network of stakeholders.
The U.S. healthcare is expensive, complex, & the incentives across stakeholders are not typically aligned.
We’re joined by industry veterans, Ali from @CalaHealth and Scott from @genentech, to talk through how startups navigate through the interconnected network of stakeholders.
We are halfway through our #ValleyReady program #Spring2022!
We have Gilly Regev, the co-founder and CEO of @SanotizeD , joining for a fireside chat to share her experience and fundraising journey. She is a biotech executive experienced in launching pharmaceutical enterprises.
What comes to your mind when you hear #advisoryboards and #boardgovernance ?
To provide valuable insight on the importance of early advisors and setting up a Board of Directors, we are extremely delighted to welcome Gloria Maceiko, @zinojorio and @HPolanen!
We are sailing onto our next workshop tomorrow on Regulatory & Medical Affairs with two captivating speakers who are back for our #ValleyReady Spring 2022 cohort.
#lifescience#SanFrancisco
This Friday we have two accomplished women joining us for a panel discussion on 'Raising Capital in the U.S.'
@jenvCA and @GunningKate , we are thrilled to have you on board!
We are excited to have 2 very accomplished & adept speakers return for our second workshop this Friday, May 20th followed by an Office Hour on May 25th. @eileenmmcmahon and Karen Towsend, from our exclusive legal partner @TorysLLP ,will be discussing How to build an IP strategy